Eledon Pharmaceuticals adopts updated director and officer indemnification agreement

Eledon Pharmaceuticals, Inc.

Board approved new form of indemnification agreement for all directors and officers.
Agreement provides indemnification to the maximum extent permitted by Delaware law.
New agreement replaces existing indemnification agreements in place with directors and executive officers.
No departures, elections, or appointments of officers were announced.
Indemnification rights are in addition to any rights under certificate of incorporation or bylaws.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.